Literature DB >> 19371817

Epidemiology of bisphosphonate-related osteonecrosis of the jaws: the utility of a national registry.

Richard Gliklich1, Jerome Wilson.   

Abstract

PURPOSE: Little is known about the epidemiology of osteonecrosis of the jaws. To date, no population-based studies have rigorously evaluated risk factors, treatment factors, or outcomes. We aimed to perform such a study.
MATERIALS AND METHODS: We reviewed the literature for epidemiologic studies on osteonecrosis of the jaws.
RESULTS: Current epidemiologic information is generally derived from anecdotal reports or case series from small institutions. Estimates that have been provided in some reports have questionable validity because of a lack of standardized case definitions, clearly defined source populations, and clear methods for obtaining (or confirming) full reporting. Population-based prospective registries are capable of answering and informing several of the outstanding questions about bisphosphonate-related osteonecrosis of the jaws/osteonecrosis of the jaws.
CONCLUSION: A population-based registry that collects systematic information on patient characteristics, treatments, and outcomes is essential to filling the gaps in our knowledge and understanding of bisphosphonate-related osteonecrosis of the jaws.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371817     DOI: 10.1016/j.joms.2009.01.005

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  9 in total

1.  Antibiotic effects on bacterial profile in osteonecrosis of the jaw.

Authors:  X Ji; S Pushalkar; Y Li; R Glickman; K Fleisher; D Saxena
Journal:  Oral Dis       Date:  2011-08-29       Impact factor: 3.511

2.  The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy.

Authors:  Satish K S Kumar; Amita Gorur; Christoph Schaudinn; Charles F Shuler; J William Costerton; Parish P Sedghizadeh
Journal:  Curr Osteoporos Rep       Date:  2010-03       Impact factor: 5.096

Review 3.  Updates on osteonecrosis of the jaw.

Authors:  Junro Yamashita; Laurie K McCauley; Catherine Van Poznak
Journal:  Curr Opin Support Palliat Care       Date:  2010-09       Impact factor: 2.302

4.  Osteonecrosis of the jaw and bevacizumab therapy.

Authors:  Catherine Van Poznak
Journal:  Breast Cancer Res Treat       Date:  2010-05-13       Impact factor: 4.872

Review 5.  A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis.

Authors:  Roberto Sacco; Gianluca Sacco; Alessandro Acocella; Silvana Sale; Nicola Sacco; Edoardo Baldoni
Journal:  J Appl Oral Sci       Date:  2011-08       Impact factor: 2.698

6.  Cloud-Based Multicenter Data Collection and Epidemiologic Analysis of Bisphosphonate-Related Osteonecrosis of the Jaws in a Central European Population.

Authors:  Tamás Vereb; Krisztina Boda; László Czakó; Mihály Vaszilkó; Gábor Fülöp; Gusztáv Klenk; Ágnes Janovszky; Ferenc Oberna; József Piffkó; László Seres
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

7.  Up to 7% of referrals to oral and maxillofacial surgery are related to medication-related osteonecrosis of the jaws: how much is really out there?

Authors:  Ailish Clark; Iain Pretty
Journal:  BDJ Open       Date:  2022-02-22

8.  Decreasing frequency of osteonecrosis of the jaw in cancer and myeloma patients treated with bisphosphonates: the experience of the oncology network of piedmont and aosta valley (north-Western Italy).

Authors:  Vittorio Fusco; Claudia Galassi; Alfredo Berruti; Cinzia Ortega; Libero Ciuffreda; Matteo Scoletta; Franco Goia; Mario Migliario; Anna Baraldi; Mario Boccadoro; Anastasios Loidoris; Oscar Bertetto
Journal:  ISRN Oncol       Date:  2013-02-27

Review 9.  Bisphophonates related osteonecrosis of the jaw.

Authors:  Swati Gupta; Hemant Gupta; Devendra Mandhyan; Sanjeev Srivastava
Journal:  Natl J Maxillofac Surg       Date:  2013-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.